Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inhaled Drug Dose”

68 trials

Showing 20 of 68 results

Early research (Phase 1)Study completedNCT03398421
What this trial is testing

Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 20
Testing effectiveness (Phase 2)Study completedNCT00314509
What this trial is testing

Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)

Who this might be right for
Asthma
AstraZeneca 240
Testing effectiveness (Phase 2)Study completedNCT00603382
What this trial is testing

Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.

Who this might be right for
Asthma
GlaxoSmithKline 599
Testing effectiveness (Phase 2)UnknownNCT04278040
What this trial is testing

Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis

Who this might be right for
Non-cystic Fibrosis Bronchiectasis
Federal State Budgetary Institution, Pulmonology Scientific Research Institute 7
Large-scale testing (Phase 3)Study completedNCT02242487
What this trial is testing

Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 325
Early research (Phase 1)Study completedNCT04769869
What this trial is testing

A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma

Who this might be right for
Asthma
AstraZeneca 110
Early research (Phase 1)Study completedNCT04072562
What this trial is testing

Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.

Who this might be right for
Asthma
AstraZeneca 24
Early research (Phase 1)Study completedNCT03754660
What this trial is testing

This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Who this might be right for
Hypertension, Pulmonary
Bayer 38
Testing effectiveness (Phase 2)Study completedNCT00358488
What this trial is testing

Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 54
Early research (Phase 1)Study completedNCT04564456
What this trial is testing

A Pivotal Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 500/50 Inhalation Powder/GSK in Healthy Volunteers

Who this might be right for
Bioequivalence
Respirent Pharmaceuticals Co Ltd. 34
Early research (Phase 1)Study completedNCT04466176
What this trial is testing

A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Who this might be right for
Bioequivalence
Respirent Pharmaceuticals Co Ltd. 34
Testing effectiveness (Phase 2)Study completedNCT01576718
What this trial is testing

The Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Who this might be right for
Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 889
Early research (Phase 1)Study completedNCT04462822
What this trial is testing

A Pilot Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Who this might be right for
Bioequivalence
Respirent Pharmaceuticals Co Ltd. 14
Very early researchStudy completedNCT04011709
What this trial is testing

A Methodology Trial Using the VR647 Inhalation System in Pediatric Subjects Who Have Previously Received Inhaled Therapy

Who this might be right for
CoughWheezing
Vectura Limited 41
Early research (Phase 1)Study completedNCT04839042
What this trial is testing

A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers

Who this might be right for
Covid19
Moat Biotechnology Corporation 196
Post-approval studies (Phase 4)Study completedNCT04155047
What this trial is testing

A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Sunovion Respiratory Development Inc. 44
Early research (Phase 1)Study completedNCT01355016
What this trial is testing

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers

Who this might be right for
Drug SafetyRespiratory Syncytial Virus Infections
MicroDose Therapeutx, Inc 48
Early research (Phase 1)UnknownNCT06025214
What this trial is testing

Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers

Who this might be right for
Bioequivalence
Respirent Pharmaceuticals Co Ltd. 34
Testing effectiveness (Phase 2)Study completedNCT02948582
What this trial is testing

Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sunovion Respiratory Development Inc. 42
Testing effectiveness (Phase 2)Study completedNCT00048009
What this trial is testing

Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids

Who this might be right for
Asthma
Hoffmann-La Roche
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation